ACS Clinical Research Program
Improving surgical care and outcomes through the OPTI-Surg toolkit(Comments Off on Improving surgical care and outcomes through the OPTI-Surg toolkit)
The OPTI-Surg study evaluates an efficient screening and optimization tool for improving outcomes after major cancer surgery.
Appropriate surveillance and risk-reduction strategies for atypical ductal hyperplasia or lobular neoplasia are discussed.
An educational program developed jointly by the ACS CRP and the Society of Surgical Oncology provides surgeons with the tools they need to actively participate in clinical trials
Updates to the AJCC Cancer Staging Manual, including revisions to breast cancer staging content, are provided as is information on the manual’s second printing, including clarification of histologic codes.
Induction chemotherapy and minimally invasive transanal surgery to increase organ preservation in rectal cancer
The objectives of the NEO Trial (CCTG CO28) are described, specifically the feasibility and safety of induction chemotherapy and minimally invasive transanal surgery to allow sphincter preservation.
More in this category
- Preventing colorectal adenomas in cancer survivors: An update on the PACES/S0820 trial
- ACS CRP sponsors educational sessions at Clinical Congress 2017
- Current role of immunotherapy in urologic cancers
- Gastrectomy for cancer: What are the benefits of a minimally invasive approach?
- ACS CRP Dissemination and Implementation Committee issues call for participants in pilot project
- Interventions to promote better conversations about initial treatment for prostate cancer
- Junior investigators: Get engaged in the Alliance for Clinical Trials in Oncology
- In search of the philosopher’s stone: The ALCHEMIST study for lung cancer
- A new approach for advanced gastric cancer: Using PET scans as a biomarker of preoperative chemotherapy efficacy
- Surgery versus monitoring and endocrine therapy for low-risk DCIS: The COMET Trial
- Second edition of Operative Standards for Cancer Surgery to be published in early 2017
- Improving rectal cancer outcomes through advocacy, education, and research: The OSTRiCh Consortium and the new NAPRC
- NRG GI002: Moving the needle toward TNT in locally advanced rectal cancer
- Why is surgeon qualification important for clinical trials, and how can it be achieved?
- Two studies pave the way for preoperative therapy in pancreatic cancer patients